Monsanto Technology LLC

Monsanto Company

Sudabathula R Rao

Ganesh M Kishore

Gregory R Heck

Tedd D Elich

Salim M Hakimi

Joel E Ream

Scott R Baerson

Kenneth John Piller

Sherri M Brown

Alan P Lundstedt

Alan J Stern

Eugene W Logusch

Sherry J Logusch

Vikram P Mehrotra

Helen L Anderson

Mark Miller

Tracy A Powers

Parker A Smith

Michaela H Feiner

Kali C Williams

Provided herein are processes for the preparation of treated seeds. Generally, the processes described herein comprise contacting a seed with a liquid seed treatment composition, thereby producing a wetted seed. The processes further comprise contacting the wetted seed with a dry powder comprising an effect pigment, thereby producing a treated seed having a coating comprising the effect pigment. In some instances, the treated seeds may exhibit an attractive visual appearance and good flowability through manufacturing, distribution, and planting equipment.

Processes for the preparation of treated seeds

Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-&#x3b2; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3&#x3b2;-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2&#x3b2;,3&#x3b2;-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.

Methods for controlling gibberellin levels

Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase, 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing antisense RNA which suppresses the gibberellin biosynthetic pathway sequence. The antisense sequence is the complement of a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, or a C20-oxidase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.

There is provided an aqueous dispersion of microcapsules containing the herbicide clomazone dissolved in an inert high boiling organic solvent which is an edible oil. Vapor transfer of the herbicide outside the targeted area is controlled without substantial sacrifice of the efficacy of the herbicide.

Microencapsulated herbicidal compositions comprising clomazone and

There is provided an aqueous dispersion of microcapsules containing the herbicide clomazone dissolved in an inert high boiling organic solvent. Vapor transfer of the herbicide outside the targeted area is controlled without substantial sacrifice of the efficacy of the herbicide.

Herbicidal microencapsulated clomazone compositions with reduced vapor

Growing community of inventors

Wildwood, MO, United States of America

Sudabathula R Rao